@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
# - resource -------------------------------------------------------------------
a fhir:Medication ;
fhir:nodeRole fhir:treeRoot ;
fhir:id [ fhir:v "Medication-Without-Strength-Code"] ; #
fhir:meta [
( fhir:profile [
fhir:v "https://gematik.de/fhir/tiflow-xborder/StructureDefinition/GEM-ERPEU-PR-Medication"^^xsd:anyURI ;
fhir:l <https://gematik.de/fhir/tiflow-xborder/StructureDefinition/GEM-ERPEU-PR-Medication> ] )
] ; #
fhir:text [
fhir:status [ fhir:v "generated" ] ;
fhir:div [ fhir:v "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: Medication Medication-Without-Strength-Code</b></p><a name=\"Medication-Without-Strength-Code\"> </a><a name=\"hcMedication-Without-Strength-Code\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-GEM-ERPEU-PR-Medication.html\">EU-Medication</a></p></div><p><b>code</b>: <span title=\"Codes:\">Infusion bestehend aus 85mg Doxorubicin aufgeloest zur Verabreichung in 250ml 5-%iger (50 mg/ml) Glucose-Infusionsloesung</span></p><p><b>form</b>: <span title=\"Codes:{http://standardterms.edqm.eu 11210000}\">Solution for infusion</span></p><h3>Ingredients</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Item[x]</b></td><td><b>IsActive</b></td><td><b>Strength</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{http://fhir.de/CodeSystem/bfarm/atc L01DB01}\">Doxorubicin</span></td><td>true</td><td>85 mg/250 Milliliter</td></tr></table></div>"^^rdf:XMLLiteral ]
] ; #
fhir:code [
fhir:text [ fhir:v "Infusion bestehend aus 85mg Doxorubicin aufgeloest zur Verabreichung in 250ml 5-%iger (50 mg/ml) Glucose-Infusionsloesung" ]
] ; #
fhir:form [
( fhir:coding [
fhir:system [
fhir:v "http://standardterms.edqm.eu"^^xsd:anyURI ;
fhir:l <http://standardterms.edqm.eu> ] ;
fhir:code [ fhir:v "11210000" ] ;
fhir:display [ fhir:v "Solution for infusion" ] ] )
] ; #
fhir:ingredient ( [
fhir:item [
a fhir:CodeableConcept ;
( fhir:coding [
fhir:system [
fhir:v "http://fhir.de/CodeSystem/bfarm/atc"^^xsd:anyURI ;
fhir:l <http://fhir.de/CodeSystem/bfarm/atc> ] ;
fhir:version [ fhir:v "2024" ] ;
fhir:code [ fhir:v "L01DB01" ] ;
fhir:display [ fhir:v "Doxorubicin" ] ] ) ] ;
fhir:isActive [ fhir:v true ] ;
fhir:strength [
fhir:numerator [
fhir:value [ fhir:v "85"^^xsd:decimal ] ;
fhir:unit [ fhir:v "mg" ] ] ;
fhir:denominator [
fhir:value [ fhir:v "250"^^xsd:decimal ] ;
fhir:unit [ fhir:v "Milliliter" ] ] ]
] ) . #
IG © 2026+ gematik GmbH. Paket de.gematik.tiflow.xborder#2.0.0-ballot.1 basierend auf FHIR 4.0.1. Generiert 2026-05-29
Links: Table of Contents |
QA Report